Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Controlled Trial ◽

Inhaled Corticosteroid ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty of 1000 evaluation for Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718003052.793477487 ◽

2013 ◽

Author(s):

Phillip Lieberman

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial

The Laryngoscope ◽

10.1002/lary.23935 ◽

2013 ◽

Vol 123 (6) ◽

pp. 1334-1340 ◽

Cited By ~ 40

Author(s):

De-Hui Wang ◽

Lei Chen ◽

Lei Cheng ◽

Ke-Nan Li ◽

Hu Yuan ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-blind, Placebo-controlled Trial

The Journal of Allergy and Clinical Immunology In Practice ◽

10.1016/j.jaip.2021.10.060 ◽

2021 ◽

Author(s):

Sarah Sella Langer ◽

Renata Nahas Cardili ◽

Janaina Michelle Lima Melo ◽

Mariana Paes Leme Ferriani ◽

Adriana Santos Moreno ◽

...

Keyword(s):

Atopic Dermatitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

Clinical and Translational Allergy ◽

10.1186/s13601-017-0180-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 11

Author(s):

Andrzej Bożek ◽

Krzysztof Kołodziejczyk ◽

Renata Kozłowska ◽

Giorgio Walter Canonica

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Subcutaneous Immunotherapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children

Pediatric Allergy and Immunology ◽

10.1111/j.1399-3038.1997.tb00138.x ◽

1997 ◽

Vol 8 (1) ◽

pp. 21-27 ◽

Cited By ~ 127

Author(s):

Th. Hirsch ◽

M. Sähn ◽

W. Leupold

Keyword(s):

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Mite Extract ◽

Dust Mite ◽

House Dust Mite Extract

Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study

Journal of Asthma ◽

10.1080/02770903.2018.1541353 ◽

2018 ◽

Vol 56 (12) ◽

pp. 1347-1355 ◽

Cited By ~ 3

Author(s):

Kazuhiro Okamiya ◽

Hisakuni Sekino ◽

Ryuji Azuma ◽

Minoru Kudo ◽

Miyuki Sakaguchi ◽

...

Keyword(s):

Phase I ◽

House Dust ◽

House Dust Mite ◽

Safety Profile ◽

Phase I Study ◽

Japanese Adult ◽

Double Blind ◽

Double Blind Placebo ◽

House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis

Clinical & Experimental Allergy ◽

10.1111/cea.12039 ◽

2013 ◽

Vol 43 (2) ◽

pp. 242-248 ◽

Cited By ~ 64

Author(s):

A. Bozek ◽

B. Ignasiak ◽

B. Filipowska ◽

J. Jarzab

Keyword(s):

Allergic Rhinitis ◽

Elderly Patients ◽

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Safety profile of the SQ house dust mite (HDM) sublingual immunotherapy-tablet in Japanese adult patients with HDM-induced allergic asthma : A randomized double-blind placebo-controlled phase I trial

10.26226/morressier.5acdc661d462b8029238d87a ◽

2018 ◽

Author(s):

Yuriko Maekawa

Keyword(s):

Phase I ◽

House Dust ◽

House Dust Mite ◽

Safety Profile ◽

Phase I Trial ◽

Japanese Adult ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment

BMC Family Practice ◽

10.1186/1471-2296-9-59 ◽

2008 ◽

Vol 9 (1) ◽

Cited By ~ 12

Author(s):

Cindy MA de Bot ◽

Heleen Moed ◽

Marjolein Y Berger ◽

Esther Röder ◽

Hans de Groot ◽

...

Keyword(s):

Primary Care ◽

House Dust Mite ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

House Dust Mite Allergy ◽

Mite Allergy ◽

Dust Mite ◽

Care Study

Sublingual immunotherapy with house dust mite allergen in children with allergic rhinitis: randomised double-blind placebo-controlled trial

http://isrctn.org/> ◽

10.1186/isrctn91141483 ◽

2012 ◽

Author(s):

H. Moed

Keyword(s):

Allergic Rhinitis ◽

House Dust Mite ◽

Controlled Trial ◽

Mite Allergen ◽

Double Blind ◽

House Dust Mite Allergen ◽

Double Blind Placebo ◽

Dust Mite ◽

Dust Mite Allergen